Table of Contents
Journal of Biomarkers
Volume 2014, Article ID 624930, 9 pages
http://dx.doi.org/10.1155/2014/624930
Research Article

Diagnosis of Non-ST-Elevation Acute Coronary Syndrome by the Measurement of Heart-Type Fatty Acid Binding Protein in Serum: A Prospective Case Control Study

1Department of Biochemistry, Nizam’s Institute of Medical Sciences, Punjagutta, Hyderabad, Andhra Pradesh 500082, India
2Department of Cardiology, Nizam’s Institute of Medical Sciences, Punjagutta, Hyderabad, Andhra Pradesh 500082, India

Received 30 September 2013; Revised 18 December 2013; Accepted 19 December 2013; Published 5 February 2014

Academic Editor: Valeria Matranga

Copyright © 2014 Priscilla Abraham Chandran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. S. Alpert, K. Thygesen, E. Antman, and J. P. Bassand, “Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction,” Journal of the American College of Cardiology, vol. 36, pp. 959–969, 2000. View at Google Scholar · View at Scopus
  2. K. Lewandrowski, A. Chen, and J. Januzzi, “Cardiac markers for myocardial infarction: a brief review,” The American journal of clinical pathology, vol. 118, supplement 1, pp. S93–S99, 2002. View at Google Scholar · View at Scopus
  3. M. Pelsers, T. Hanhoff, D. van der Voort et al., “Tissue specific types of fatty acid-binding proteins, B- and H-FABP, as novel markers for detection of brain injury,” Clinical Chemistry and Laboratory Medicine, vol. 50, pp. 1568–1575, 2004. View at Google Scholar
  4. T. J. Ryan, E. Antman, N. H. Brooks et al., “Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction),” Journal of the American College of Cardiology, vol. 34, pp. 890–911, 1999. View at Google Scholar
  5. P. O. Collinson, “The need for a point of care testing: an evidence-based appraisal,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 59, no. 230, pp. 67–73, 1999. View at Google Scholar · View at Scopus
  6. L. James Januzzi, Cardiac Biomarkers in Clinical Practice, Jones and Bartlet publishers, 1st edition, 2011.
  7. M. M. Pelsers, W. T. Hermens, and J. F. C. Glatz, “Fatty acid-binding proteins as plasma markers of tissue injury,” Clinica Chimica Acta, vol. 352, no. 1-2, pp. 15–35, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Seino, Y. Tomita, T. Takano, and K. Ohbayashi, “Office cardiologists cooperative study on whole blood rapid panel tests in patients with suspicious Acute myocardial infarction: comparison between heart-type fatty acid-binding protein and troponin T tests,” Circulation Journal, vol. 68, no. 2, pp. 144–148, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. H. M. E. Azzazy, M. M. Pelsers, and R. H. Christenson, “Unbound free fatty acids and heart-type fatty acid-binding protein: diagnostic assays and clinical applications,” Clinical Chemistry, vol. 52, no. 1, pp. 19–29, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. T. A. Lang and M. Secic, How to Report Statistics in Medicine, American College of Physicians, Philadelphia, Pa, USA, 1997.
  11. W. J. Youden, “Index for rating diagnostic tests,” Cancer, vol. 3, no. 1, pp. 32–35, 1950. View at Google Scholar · View at Scopus
  12. X.-H. Zhou, N. Obuchowski, and D. McClish, “Statistical methods in diagnostic medicine,” Pharmaceutical Statistics, vol. 2, no. 4, pp. 304–305, 2003. View at Google Scholar
  13. B. Phillips and M. Westwood, “Testing our understanding of tests,” Archives of Disease in Childhood, vol. 94, no. 3, pp. 178–179, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S. M. Salerno, P. C. Alguire, and H. S. Waxman, “Competency in interpretation of 12-lead electrocardiograms: a summary and appraisal of published evidence,” Annals of Internal Medicine, vol. 138, no. 9, pp. 751–760, 2003. View at Google Scholar · View at Scopus
  15. C. W. Hamm, J.-P. Bassand, S. Agewall et al., “ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation,” European Heart Journal, vol. 32, no. 23, pp. 2999–3054, 2011. View at Google Scholar · View at Scopus
  16. D. A. Morrow, C. P. Cannon, R. L. Jesse et al., “National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes,” Clinical Chemistry, vol. 53, no. 4, pp. 552–574, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Panteghini, F. Pagani, and G. Bonetti, “The sensitivity of cardiac markers: an evidence-based approach,” Clinical Chemistry and Laboratory Medicine, vol. 37, no. 11-12, pp. 1097–1106, 1999. View at Google Scholar · View at Scopus
  18. S. J. Maynard, I. B. A. Menown, and A. A. J. Adgey, “Troponin T or troponin I as cardiac markers in ischaemic heart disease,” Heart, vol. 83, no. 4, pp. 371–373, 2000. View at Google Scholar · View at Scopus
  19. G. X. Brogan Jr., S. Friedman, C. McCuskey et al., “Evaluation of a new rapid quantitative immunoassay for serum myoglobin versus CK-MB for ruling out acute myocardial infarction in the emergency department,” Annals of Emergency Medicine, vol. 24, no. 4, pp. 665–671, 1994. View at Google Scholar · View at Scopus
  20. V. Scharnhorst, K. Krasznai, M. V. Veer, and R. Michels, “Rapid detection of myocardial infarction with a sensitive troponin test,” The American Journal of Clinical Pathology, vol. 135, no. 3, pp. 424–428, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Kurz, E. Giannitsis, M. Becker, G. Hess, D. Zdunek, and H. A. Katus, “Comparison of the new high sensitive cardiac troponin T with myoglobin, h-FABP and cTnT for early identification of myocardial necrosis in the acute coronary syndrome,” Clinical Research in Cardiology, vol. 100, no. 3, pp. 209–215, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Amodio, G. Antonelli, L. Varraso, V. Ruggieri, and F. Di Serio, “Clinical impact of the troponin 99th percentile cut-off and clinical utility of myoglobin measurement in the early management of chest pain patients admitted to the Emergency Cardiology Department,” Coronary Artery Disease, vol. 18, no. 3, pp. 181–186, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Reichlin, W. Hochholzer, S. Bassetti et al., “Early diagnosis of myocardial infarction with sensitive cardiac troponin assays,” The New England Journal of Medicine, vol. 361, no. 9, pp. 858–867, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. F. A. Van Nieuwenhoven, A. H. Kleine, K. W. H. Wodzig et al., “Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein,” Circulation, vol. 92, no. 10, pp. 2848–2854, 1995. View at Google Scholar · View at Scopus
  25. T. Tanaka, Y. Hirota, K.-I. Sohmiya, S. Nishimura, and K. Kawamura, “Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction,” Clinical Biochemistry, vol. 24, no. 2, pp. 195–201, 1991. View at Google Scholar · View at Scopus
  26. K. Watanabe, H. Wakabayashi, J. H. Veerkamp, T. Ono, and T. Suzuki, “Immunohistochemical distribution of heart-type fatty acid-binding protein immunoreactivity in normal human tissues and in acute myocardial infarct,” Journal of Pathology, vol. 170, no. 1, pp. 59–65, 1993. View at Google Scholar · View at Scopus
  27. C. G. McMahon, J. V. Lamont, E. Curtin et al., “Diagnostic accuracy of heart-type fatty acid-binding protein for the early diagnosis of acute myocardial infarction,” The American Journal of Emergency Medicine, vol. 30, no. 2, pp. 267–274, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. J. F. C. Glatz, A. H. Kleine, F. A. van Nieuwenhoven, W. T. Hermens, M. P. van Dieijen-Visser, and G. J. Van der Vusse, “Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans,” British Heart Journal, vol. 71, no. 2, pp. 135–140, 1994. View at Google Scholar · View at Scopus
  29. K. Will Wodzig, J. A. Kragten, W. T. Hermens, J. F. C. Glatz, and M. P. Van Dieijen-Visser, “Estimation of myocardial infarct size from plasma myoglobin or fatty acid-binding protein: influence of renal function,” European Journal of Clinical Chemistry and Clinical Biochemistry, vol. 35, no. 3, pp. 191–198, 1997. View at Google Scholar · View at Scopus
  30. E. C. H. J. Michielsen, J. H. C. Diris, V. W. V. C. Kleijnen, W. K. W. H. Wodzig, and M. P. Van Dieijen-Visser, “Interpretation of cardiac troponin T behaviour in size-exclusion chromatography,” Clinical Chemistry and Laboratory Medicine, vol. 44, no. 12, pp. 1422–1427, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. H. A. Alhadi and K. A. A. Fox, “Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid-binding protein,” Monthly Journal of the Association of Physicians, vol. 97, no. 4, pp. 187–198, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. C. J. McCann, B. M. Glover, I. B. A. Menown et al., “Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T,” European Heart Journal, vol. 29, no. 23, pp. 2843–2850, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. C.-J. Li, J.-Q. Li, X.-F. Liang et al., “Point-of-care test of heart-type fatty acid-binding protein for the diagnosis of early acute myocardial infarction,” Acta Pharmacologica Sinica, vol. 31, no. 3, pp. 307–312, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Body, G. McDowell, S. Carley, C. Wibberley, J. Ferguson, and K. Mackway-Jones, “A FABP-ulous “rule out” strategy? Heart fatty acid binding protein and troponin for rapid exclusion of acute myocardial infarction,” Resuscitation, vol. 82, no. 8, pp. 1041–1046, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. Q. Xu, C. P. Y. Chan, X.-Y. Cao et al., “Cardiac multi-marker strategy for effective diagnosis of acute myocardial infarction,” Clinica Chimica Acta, vol. 411, no. 21-22, pp. 1781–1787, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. T. S. Hall, J. Hallén, S. Agewall, D. Atar, and T. Jensen, “Changes in diagnosing non-ST-segment elevation myocardial infarction after the introduction of a new high-sensitivity cardiac troponin T assay: a single-centre experience,” Clinical Laboratory, vol. 58, no. 9-10, pp. 1029–1036, 2012. View at Google Scholar
  37. M. M. Pelsers, J.-P. Chapelle, M. Knapen et al., “Influence of age and sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects,” Clinical Chemistry, vol. 45, no. 3, pp. 441–443, 1999. View at Google Scholar · View at Scopus
  38. A. Kathrukha, A. Bereznikova, V. Filatov, and T. Esakova, “Improved detection of minor ischemic cardiac injury in patients with unstable angina by measurement of cTnI and fatty acid-binding protein (FABP),” Clinical Chemistry, vol. 45, article A139, 1999. View at Google Scholar
  39. F. Pagani, R. Bonora, G. Bonetti, and M. Panteghini, “Evaluation of a sandwich enzyme-linked immunosorbent assay for the measurement of serum heart fatty acid-binding protein,” Annals of Clinical Biochemistry, vol. 39, no. 4, pp. 404–405, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Nakata, A. Hashimoto, M. Hase, K. Tsuchihashi, and K. Shimamoto, “Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome,” Cardiology, vol. 99, no. 2, pp. 96–104, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Hafidh Alhadi and A. A. Keith Fox, “Clinical and basic research: heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction. The potential for influencing patient management,” SQU Medical Journal, vol. 10, no. 1, pp. 41–49, 2010. View at Google Scholar
  42. “Cheaper Chest Pain Screening In Emergency Rooms Offered By New CT Technology,” http://www.medicalnewstoday.com/.
  43. S. Saddichha and M. K. Saxena, “Is every chest pain a cardiac event?: an audit of patients with chest pain presenting to emergency services in India,” Internal and Emergency Medicine, vol. 4, no. 3, pp. 235–239, 2009. View at Publisher · View at Google Scholar · View at Scopus